Niramai Health Analytix logo

Niramai Health Analytix

A non-contact privacy-aware breast cancer screening solution that detects early stage breast abnormalities.

74 employees · est. 2016 · Bengaluru, India

VS
ScreenPoint Medical logo

ScreenPoint Medical

The Breast AI Company: Leading the way in early breast cancer detection.

86 employees · est. 2014 · Nijmegen, The Netherlands

ScreenPoint Medical is the older company (2016 vs 2014).

Side-by-Side Comparison

Niramai Health Analytix ScreenPoint Medical
Founded
2016 2014 older
Headquarters
Bengaluru, India Nijmegen, The Netherlands
Employees
74 86
Industry
Health Care AI, Analytics, Machine Learning
Funding Stage
Unknown Series C
Total Funding
$7.18M $46.80M
Funding Rounds
9 5
Services
Not tracked yet Transpara Breast AI, Breast Cancer Detection, Breast Density Analysis, AI-enhanced Imaging Workflow, Temporal Comparison in Mammography
Target Customers
Not tracked yet Radiologists, Breast Imaging Centers, Hospitals and Clinics, Health Systems, Screening Programs
Taxonomy
Health Tech, AI-based Healthcare, Breast Cancer Screening, Deep Learning Algorithms, Thermography, Medical Imaging, Non-invasive Screening, Women's Health, Early Cancer Detection, Medical Technology, Privacy-aware Solutions AI-powered Technology, Breast Cancer Detection, Breast Radiology, Personalized Care Pathways, Deep Learning, Image Analysis, Mammogram Reading, Digital Breast Tomosynthesis, Computer-aided Detection (CAD), Medical Imaging, Decision Support, Machine Learning, Clinical Deployment, Breast Health Solutions, Automated Mammogram Analysis
Website
niramai.com screenpoint-medical.com
Niramai Health Analytix logo

About Niramai Health Analytix

Niramai Health Analytix is a pioneering health tech startup founded in 2016 and headquartered in India, specializing in the early detection of breast cancer through its innovative Thermalytix® technology. Their solution provides a non-contact privacy-aware breast cancer screening offering, which is...

ScreenPoint Medical logo

About ScreenPoint Medical

ScreenPoint Medical, founded in 2014 and based in The Netherlands, defines itself as The Breast AI Company, leading the way in early breast cancer detection. Their slogan emphasizes their commitment: "The Breast AI Company: Leading the way in early breast cancer detection." The firm specializes in...

We will tell you when either one moves

BounceWatch watches Niramai Health Analytix and ScreenPoint Medical for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Niramai Health Analyti... and ScreenPoint Medical — by email.

Frequently Asked Questions

Niramai Health Analytix — A non-contact privacy-aware breast cancer screening solution that detects early stage breast abnormalities.. ScreenPoint Medical — The Breast AI Company: Leading the way in early breast cancer detection.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Niramai Health Analytix has raised $7.18M while ScreenPoint Medical has raised $46.80M.
Niramai Health Analytix and ScreenPoint Medical operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Niramai Health Analytix with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Niramai Health Analytix on 29 Apr 2026, and ScreenPoint Medical on 8 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes